• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人参果实中分离得到的天然产物的体外抗癌活性及构效关系

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.

作者信息

Wang Wei, Zhao Yuqing, Rayburn Elizabeth R, Hill Donald L, Wang Hui, Zhang Ruiwen

机构信息

Department of Pharmacology and Toxicology, Division of Clinical Pharmacology, Cancer Pharmacology Laboratory, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Cancer Chemother Pharmacol. 2007 Apr;59(5):589-601. doi: 10.1007/s00280-006-0300-z. Epub 2006 Aug 22.

DOI:10.1007/s00280-006-0300-z
PMID:16924497
Abstract

PURPOSE

Panax ginseng and its extracts have long been used for medical purposes; there is increasing interest in developing ginseng products as cancer preventive or therapeutic agents. The present study was designed to determine biological structure-activity relationships (SAR) for saponins present in Panax ginseng fruits.

METHODS

Eleven saponins were extracted from P. ginseng fruits and purified by use of D(101) resin and ordinary and reverse-phase silica gel column chromatography. Their chemical structures were elucidated on the basis of physicochemical constants and NMR spectra. Compounds were then evaluated for SAR with their in vitro cytotoxicity against several human cancer cell lines.

RESULTS

The 11 compounds were identified as 20(R)-dammarane-3beta,12beta,20,25-tetrol (25-OH-PPD, 1); 20(R)-dammarane-3beta,6alpha,12beta,20,25-pentol (25-OH-PPT, 2); 20(S)-protopanaxadiol (PPD, 3); daucosterine 4, 20(S)-ginsenoside-Rh(2) (Rh(2), 5); 20(S)-ginsenoside-Rg(3) (Rg(3,) 6); 20(S)-ginsenoside-Rg(2) (Rg(2), 7); 20(S)-ginsenoside-Rg(1) (Rg(1), 8); 20(S)-ginsenoside-Rd (Rd, 9); 20(S)-ginsenoside-Re (Re, 10); and 20(S)-ginsenoside-Rb(1) (Rb(1), 11). Among the eleven compounds, 1, 3 and 5 were the most effective inhibitors of cell growth and proliferation and inducers of apoptosis and cell cycle arrest. For 1, the IC(50) values for most cell lines were in the range of 10-60 microM, at least twofold lower than for any of the other compounds. Compounds 1 and 3 had significant, dose-dependent effects on apoptosis, proliferation, and cell cycle progression.

CONCLUSIONS

The results suggest that the type of dammarane, the number of sugar moieties, and differences in the substituent groups affect their anti-cancer activity. This information may be useful for evaluating the structure/function relationship of other ginsenosides and their aglycones and for development of novel anticancer agents.

摘要

目的

人参及其提取物长期以来一直用于医学目的;人们对开发人参产品作为癌症预防或治疗剂的兴趣与日俱增。本研究旨在确定人参果实中皂苷的生物构效关系(SAR)。

方法

从人参果实中提取11种皂苷,并通过D(101)树脂以及普通和反相硅胶柱色谱法进行纯化。根据物理化学常数和核磁共振光谱阐明其化学结构。然后评估这些化合物对几种人类癌细胞系的体外细胞毒性的构效关系。

结果

这11种化合物被鉴定为20(R)-达玛烷-3β,12β,20,25-四醇(25-OH-PPD,1);20(R)-达玛烷-3β,6α,12β,20,25-五醇(25-OH-PPT,2);20(S)-原人参二醇(PPD,3);胡萝卜苷4,20(S)-人参皂苷-Rh(2)(Rh(2),5);20(S)-人参皂苷-Rg(3)(Rg(3),6);20(S)-人参皂苷-Rg(2)(Rg(2),7);20(S)-人参皂苷-Rg(1)(Rg(1),8);20(S)-人参皂苷-Rd(Rd,9);20(S)-人参皂苷-Re(Re,10);以及20(S)-人参皂苷-Rb(1)(Rb(1),11)。在这11种化合物中,1、3和5是细胞生长和增殖的最有效抑制剂,也是细胞凋亡和细胞周期停滞的诱导剂。对于化合物1,大多数细胞系的IC(50)值在10 - 60微摩尔范围内,至少比其他任何化合物低两倍。化合物1和3对细胞凋亡、增殖和细胞周期进程具有显著的剂量依赖性作用。

结论

结果表明达玛烷类型、糖基数量以及取代基的差异会影响它们的抗癌活性。这些信息可能有助于评估其他人参皂苷及其苷元的结构/功能关系,并有助于开发新型抗癌药物。

相似文献

1
In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.从人参果实中分离得到的天然产物的体外抗癌活性及构效关系
Cancer Chemother Pharmacol. 2007 Apr;59(5):589-601. doi: 10.1007/s00280-006-0300-z. Epub 2006 Aug 22.
2
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities.人参果中新达玛烷型甾体皂苷及其生物活性。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):1027-31. doi: 10.1016/j.bmcl.2010.12.035. Epub 2010 Dec 10.
3
Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells.高丽红参和白参中人参皂甙的细胞摄取及其对人乳腺癌细胞的凋亡活性。
Planta Med. 2011 Jan;77(2):133-40. doi: 10.1055/s-0030-1250160. Epub 2010 Jul 28.
4
Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng.三七中一种新型天然产物20(S)-25-甲氧基-达玛烷-3β,12β,20-三醇[20(S)-25-OCH3-PPD]的分离、结构鉴定及生物活性评价
Med Chem. 2007 Jan;3(1):51-60. doi: 10.2174/157340607779317508.
5
Three new dammarane-type triterpene saponins from the leaves of Panax ginseng C.A. Meyer.从人参(Panax ginseng C.A. Meyer)叶中分离得到的三种新达玛烷型三萜皂苷。
J Asian Nat Prod Res. 2010 Oct;12(10):865-73. doi: 10.1080/10286020.2010.508035.
6
Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng.人参皂苷Rh4,一种来自韩国红参的纯正达玛烷糖苷。
Planta Med. 1996 Feb;62(1):86-7. doi: 10.1055/s-2006-957816.
7
A new triterpenoid from Panax ginseng exhibits cytotoxicity through p53 and the caspase signaling pathway in the HepG2 cell line.一种来自人参的新型三萜类化合物通过p53和半胱天冬酶信号通路在HepG2细胞系中表现出细胞毒性。
Arch Pharm Res. 2008 Mar;31(3):323-9. doi: 10.1007/s12272-001-1159-8. Epub 2008 Apr 13.
8
[Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].[人参皂苷衍生化及其抗肿瘤构效关系的研究进展]
Yao Xue Xue Bao. 2012 Jul;47(7):836-43.
9
Isoginsenoside-Rh3, a new triterpenoid saponin from the fruits of Panax ginseng C. A. Mey.异人参皂苷-Rh3,一种来自人参(Panax ginseng C. A. Mey.)果实的新型三萜皂苷。
J Asian Nat Prod Res. 2004 Dec;6(4):289-93. doi: 10.1080/10286020310001595980.
10
Quinquenoside F₆, a new triterpenoid saponin from the fruits of Panax quinquefolium L.五加果 F₆,一种从西洋参果实中提取的新三萜皂苷。
Nat Prod Res. 2012;26(15):1395-401. doi: 10.1080/14786419.2011.592833. Epub 2011 Oct 19.

引用本文的文献

1
Production of rare ginsenosides by biotransformation of Panax notoginseng saponins using Aspergillus fumigatus.利用烟曲霉对三七皂苷进行生物转化生产稀有人参皂苷
Bioresour Bioprocess. 2024 Aug 9;11(1):81. doi: 10.1186/s40643-024-00794-0.
2
Aphrodisiac Principles and other Constituents from the Roots of and .来自[植物名称1]和[植物名称2]根部的壮阳成分及其他成分。 (你提供的原文中植物名称缺失,请补充完整以便更准确翻译)
ACS Omega. 2024 Jul 18;9(30):33239-33250. doi: 10.1021/acsomega.4c04965. eCollection 2024 Jul 30.
3
Biotransformation and pharmacological activities of platycosides from roots.
桔梗根中桔梗皂苷的生物转化及药理活性
Chin Herb Med. 2024 Apr 30;16(3):392-400. doi: 10.1016/j.chmed.2024.01.004. eCollection 2024 Jul.
4
Characteristics of Aqueous Chemical Species Generation in Plasma-Facing Liquid Systems Using Helium Jet Plasma.使用氦气喷射等离子体的面向等离子体液体系统中水性化学物质生成的特性。
ChemistryOpen. 2024 Jul;13(7):e202300213. doi: 10.1002/open.202300213. Epub 2024 May 27.
5
Stereospecificity of Ginsenoside AD-1 and AD-2 Showed Anticancer Activity via Inducing Mitochondrial Dysfunction and Reactive Oxygen Species Mediate Cell Apoptosis.人参皂苷AD-1和AD-2的立体特异性通过诱导线粒体功能障碍和活性氧介导的细胞凋亡显示出抗癌活性。
Molecules. 2023 Sep 19;28(18):6698. doi: 10.3390/molecules28186698.
6
Anticancer effect of terpenes: focus on malignant melanoma.萜类化合物的抗癌作用:聚焦恶性黑素瘤。
Pharmacol Rep. 2023 Oct;75(5):1115-1125. doi: 10.1007/s43440-023-00512-1. Epub 2023 Jul 29.
7
Saponins of ginseng products: a review of their transformation in processing.人参制品中的皂苷:加工过程中其转化的综述
Front Pharmacol. 2023 Apr 28;14:1177819. doi: 10.3389/fphar.2023.1177819. eCollection 2023.
8
Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update.人参的免疫调节、抗炎和抗癌特性:药理学更新。
Molecules. 2023 May 3;28(9):3863. doi: 10.3390/molecules28093863.
9
Analysis of metabolites and metabolism-mediated biological activity assessment of ginsenosides on microfluidic co-culture system.基于微流控共培养系统的人参皂苷代谢产物分析及其代谢介导的生物活性评估
Front Pharmacol. 2023 Jan 30;14:1046722. doi: 10.3389/fphar.2023.1046722. eCollection 2023.
10
Protective effects of berry extract on blue light-induced retinal damage in ARPE-19 cells and mouse retina.浆果提取物对蓝光诱导的ARPE-19细胞和小鼠视网膜损伤的保护作用。
J Ginseng Res. 2023 Jan;47(1):65-73. doi: 10.1016/j.jgr.2022.04.002. Epub 2022 Apr 18.